Interaction of native and modified low-density lipoproteins with extracellular matrix

被引:70
作者
Chait, A [1 ]
Wight, TN
机构
[1] Univ Washington, Dept Med, Seattle, WA 98195 USA
[2] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
关键词
D O I
10.1097/00041433-200010000-00003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipoprotein-matrix interactions play an important role in arterial disease. Extracellular matrix proteoglycans bind and retain specific positively charged domains on apolipoproteins B- and E-containing lipoproteins during atherogenesis. Retained lipoproteins can undergo several modifications, which may alter their interaction with extracellular matrix molecules. Growth factors, cytokines and oxidized low density lipoproteins influence proteoglycan structure, rendering them more likely to bind and retain lipoproteins during atherogenesis. Lipoproteins, native and modified, also can modulate the expression of several of the matrix degrading enzymes present in vascular tissue, thereby influencing plague stability. Thus, the interaction of atherogenic lipoproteins with arterial wail matrix molecules can influence the genesis and progression of atherosclerosis and its complications. Curr Opin Lipidol 11:457-463. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:457 / 463
页数:7
相关论文
共 63 条
[1]   Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma - A potential mechanism of lesion stabilization [J].
Aikawa, M ;
Rabkin, E ;
Okada, Y ;
Voglic, SJ ;
Clinton, SK ;
Brinckerhoff, CE ;
Sukhova, GK ;
Libby, P .
CIRCULATION, 1998, 97 (24) :2433-2444
[2]   Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans [J].
Anber, V ;
Griffin, BA ;
McConnell, M ;
Packard, CJ ;
Shepherd, J .
ATHEROSCLEROSIS, 1996, 124 (02) :261-271
[3]   Identification of the principal proteoglycan-binding site in LDL -: A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding [J].
Borén, J ;
Olin, K ;
Lee, I ;
Chait, A ;
Wight, TN ;
Innerarity, TL .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (12) :2658-2664
[4]  
CAMEJO G, 1993, J BIOL CHEM, V268, P14131
[5]   CHARACTERIZATION AND PROPERTIES OF A LIPOPROTEIN-COMPLEXING PROTEOGLYCAN FROM HUMAN AORTA [J].
CAMEJO, G ;
LALAGUNA, F ;
LOPEZ, F ;
STAROSTA, R .
ATHEROSCLEROSIS, 1980, 35 (03) :307-320
[6]   PARTICIPATION OF AORTIC PROTEINS IN FORMATION OF COMPLEXES BETWEEN LOW-DENSITY LIPOPROTEINS AND INTIMA-MEDIA EXTRACTS [J].
CAMEJO, G ;
LOPEZ, A ;
VEGAS, H ;
PAOLI, H .
ATHEROSCLEROSIS, 1975, 21 (01) :77-91
[7]   IDENTIFICATION OF APO-B-100 SEGMENTS MEDIATING THE INTERACTION OF LOW-DENSITY LIPOPROTEINS WITH ARTERIAL PROTEOGLYCANS [J].
CAMEJO, G ;
OLOFSSON, SO ;
LOPEZ, F ;
CARLSSON, P ;
BONDJERS, G .
ARTERIOSCLEROSIS, 1988, 8 (04) :368-377
[8]   INTERACTION OF LOW-DENSITY LIPOPROTEINS WITH ARTERIAL PROTEOGLYCANS - THE ROLE OF CHARGE AND SIALIC-ACID CONTENT [J].
CAMEJO, G ;
LOPEZ, A ;
LOPEZ, F ;
QUINONES, J .
ATHEROSCLEROSIS, 1985, 55 (01) :93-105
[9]  
Chait Alan, 1994, Current Opinion in Lipidology, V5, P365, DOI 10.1097/00041433-199410000-00008
[10]   Low-density lipoprotein stimulates mesangial cell proteoglycan and hyaluronan synthesis [J].
Chana, RS ;
Wheeler, DC ;
Thomas, GJ ;
Williams, JD ;
Davies, M .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (02) :167-172